By Nancy Lapid (Reuters) -Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

The plea alleged that licences for these drugs were given without appropriate scientific trials, data or noted potential ...

Cinnamon, turmeric, and ginger may interact with anticoagulants and chemotherapeutics, raising bleeding risk and reducing ...

Curcumin, the active compound in turmeric, may help protect against esophageal damage caused by GERD. It has a wide range of ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Next‑Gen Amnio-Chorionic Membrane for Enhanced Wound Care is Latest Offering in a Slew of New Products Focused on Increasing Patient Care LAS VEGAS, NV / ACCESS Newswire / July 1, 2025 / New Horizon ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Metformin, a drug used as a first-line treatment for type 2 diabetes, ... (WHI) study on 438 postmenopausal women newly diagnosed with type 2 diabetes and started on anti-diabetic medication.